1. Arnold M, Morgan E, Rumgay H, Mafra A, Singh D, Laversanne M, et al. Current and future burden of breast cancer: Global statistics for 2020 and 2040. Breast 2022; 66:15-23.
2. Luque-Bolivar A, Pérez-Mora E, Villegas VE, Rondón-Lagos M. Resistance and overcoming resistance in breast cancer. Breast Cancer (Dove Med Press) 2020; 12:211-229.
3. Wen X, Klionsky DJ. At a glance: A history of autophagy and cancer. Semin Cancer Biol 2020; 66:3-11.
4. Ariosa AR, Lahiri V, Lei Y, Yang Y, Yin Z, Zhang Z, et al. A perspective on the role of autophagy in cancer. Biochim Biophys Acta Mol Basis Dis 2021; 1867:166262.
5. Ambrosio S, Majello B. Autophagy roles in genome maintenance. Cancers 2020; 12:1793-1816.
6. Maiuolo J, Gliozzi M, Musolino V, Carresi C, Scarano F, Nucera S, et al. From metabolic syndrome to neurological diseases: Role of autophagy. Front Cell Dev Biol 2021; 9:651021.
7. Hao M, Yeo SK, Turner K, Harold A, Yang Y, Zhang X, et al. Autophagy blockade limits HER2+ breast cancer tumorigenesis by perturbing HER2 trafficking and promoting release via small extracellular vesicles. Dev Cell 2021; 56:341-355.
8. Altman BJ, Rathmell JC. Metabolic stress in autophagy and cell death pathways. Cold Spring Harb Perspect Biol 2012; 4:a008763.
9. Bhutia SK, Mukhopadhyay S, Sinha N, Das DN, Panda PK, Patra SK, et al. Autophagy: Cancer’s friend or foe? Adv Cancer Res 2013; 118:61-95.
10. Kim HM, Koo JS. The role of autophagy in breast cancer metastasis. Biomedicines 2023; 11:618-636.
11. Leitzmann C. Characteristics and health benefits of phytochemicals. Forsch Komplementmed 2016; 23:69-74.
12. Kochman J, Jakubczyk K, Antoniewicz J, Mruk H, Janda K. Health benefits and chemical composition of matcha green tea: A review. Molecules 2020; 26:85-95.
13. Talib WH, Daoud S, Mahmod AI, Hamed RA, Awajan D, Abuarab SF, et al. Plants as a source of anticancer agents: From bench to bedside. Molecules 2022; 27:4818-4858.
14. Patra S, Pradhan B, Nayak R, Behera C, Panda KC, Das S, et al. Apoptosis and autophagy modulating dietary phytochemicals in cancer therapeutics: Current evidences and future perspectives. Phytother Res 2021; 35:4194-4214.
15. Mizushima N. A brief history of autophagy from cell biology to physiology and disease. Nat Cell Biol 2018; 20:521-527.
16. Nie T, Zhu L, Yang Q. The classification and basic processes of autophagy. Adv Exp Med Biol 2021; 1208:3-16.
17. Li W, He P, Huang Y, Li Y-F, Lu J, Li M, et al. Selective autophagy of intracellular organelles: Recent research advances. Theranostics 2021; 11:222-256.
18. Nishimura T, Tooze SA. Emerging roles of ATG proteins and membrane lipids in autophagosome formation. Cell Discov 2020; 6:32-49.
19. Poillet-Perez L, Despouy G, Delage-Mourroux R, Boyer-Guittaut M. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy. Redox Biol 2015; 4:184-192.
20. Li X, He S, Ma B. Autophagy and autophagy-related proteins in cancer. Mol Cancer 2020; 19:1-16.
21. Nishimura T, Tamura N, Kono N, Shimanaka Y, Arai H, Yamamoto H, et al. Autophagosome formation is initiated at phosphatidylinositol synthase‐enriched ER subdomains. EMBO J 2017; 36:1719-1735.
22. Dikic I, Elazar Z. Mechanism and medical implications of mammalian autophagy. Nat Rev Mol Cell Biol 2018; 19:349-364.
23. Hosokawa N, Hara T, Kaizuka T, Kishi C, Takamura A, Miura Y, et al. Nutrient-dependent mTORC1 association with the ULK1–Atg13–FIP200 complex required for autophagy. Mol Biol Cell 2009; 20:1981-1991.
24. Park J-M, Jung CH, Seo M, Otto NM, Grunwald D, Kim KH, et al. The ULK1 complex mediates MTORC1 signaling to the autophagy initiation machinery via binding and phosphorylating ATG14. Autophagy 2016; 12:547-564.
25. Kim J, Kundu M, Viollet B, Guan K-L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 2011; 13:132-141.
26. Hawley SA, Pan DA, Mustard KJ, Ross L, Bain J, Edelman AM, et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005; 2:9-19.
27. Egan D, Kim J, Shaw RJ, Guan KL. The autophagy initiating kinase ULK1 is regulated via opposing phosphorylation by AMPK and mTOR. Autophagy 2011; 7:643-644.
28. Kim J, Kim YC, Fang C, Russell RC, Kim JH, Fan W, et al. Differential regulation of distinct Vps34 complexes by AMPK in nutrient stress and autophagy. Cell 2013; 152:290-303.
29. Yin Z, Pascual C, Klionsky DJ. Autophagy: machinery and regulation. Microb Cell 2016; 3:588-596.
30. Levy JMM, Towers CG, Thorburn A. Targeting autophagy in cancer. Nat Rev Cancer 2017; 17:528-542.
31. Deng S, Shanmugam MK, Kumar AP, Yap CT, Sethi G, Bishayee A. Targeting autophagy using natural compounds for cancer prevention and therapy. Cancer 2019; 125:1228-1246.
32. Polson HE, de Lartigue J, Rigden DJ, Reedijk M, Urbé S, Clague MJ, et al. Mammalian Atg18 (WIPI2) localizes to omegasome-anchored phagophores and positively regulates LC3 lipidation. Autophagy 2010; 6:506-522.
33. Geng J, Klionsky DJ. The Atg8 and Atg12 ubiquitin‐like conjugation systems in macroautophagy. EMBO Rep 2008; 9:859-864.
34. Kuma A, Mizushima N, Ishihara N, Ohsumi Y. Formation of the∼ 350-kDa Apg12-Apg5· Apg16 multimeric complex, mediated by Apg16 oligomerization, is essential for autophagy in yeast. J Biol Chem 2002; 277:18619-18625.
35. Zhao YG, Codogno P, Zhang H. Machinery, regulation and pathophysiological implications of autophagosome maturation. Nat Rev Mol Cell Bio 2021; 22:733-750.
36. Kabeya Y, Mizushima N, Ueno T, Yamamoto A, Kirisako T, Noda T, et al. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J 2000; 19:5720-5728.
37. Mizushima N, Klionsky DJ. Protein turnover via autophagy: Implications for metabolism. Annu Rev Nutr 2007; 27:19-40.
38. Zaffagnini G, Martens S. Mechanisms of selective autophagy. J Mol Biol 2016; 428:1714-1724.
39. Reggiori F, Ungermann C. Autophagosome maturation and fusion. J Mol Biol 2017; 429:486-496.
40. Kriegenburg F, Ungermann C, Reggiori F. Coordination of autophagosome-lysosome fusion by Atg8 family members. Curr Biol 2018; 28:512-518.
41. Nakamura S, Yoshimori T. New insights into autophagosome-lysosome fusion. J Cell Sci 2017; 130:1209-1216.
42. Yersal O, Barutca S. Biological subtypes of breast cancer: Prognostic and therapeutic implications. World J Clin Oncol 2014; 5:412-424.
43. Cocco S, Leone A, Piezzo M, Caputo R, Di Lauro V, Di Rella F, et al. Targeting autophagy in breast cancer. Int J Mol Sci 2020; 21:7836-7856.
44. Morganti S, Ivanova M, Ferraro E, Ascione L, Vivanet G, Bonizzi G, et al. Loss of HER2 in breast cancer: Biological mechanisms and technical pitfalls. Cancer Drug Resist 2022; 5:971-980.
45. Hashemi M, Paskeh MDA, Orouei S, Abbasi P, Khorrami R, Dehghanpour A, et al. Towards dual function of autophagy in breast cancer: A potent regulator of tumor progression and therapy response. Biomed Pharmacother 2023; 161:114546.
46. Bortnik S, Tessier-Cloutier B, Leung S, Xu J, Asleh K, Burugu S, et al. Differential expression and prognostic relevance of autophagy-related markers ATG4B, GABARAP, and LC3B in breast cancer. Breast Cancer Res Treat, 2020; 183:525-547.
47. Chen W, Bai Y, Patel C, Geng F. Autophagy promotes triple negative breast cancer metastasis via YAP nuclear localization. Biochem Biophys Res Commun 2019; 520:263-268.
48. Grandvallet C, Feugeas JP, Monnien F, Despouy G, Valérie P, Michaël G, et al. Autophagy is associated with a robust specific transcriptional signature in breast cancer subtypes. Genes Cancer 2020; 11:154-168.
49. Guan X, Guan Y. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest. J BUON 2020; 25:1330-1336.
50. Cao J, Zhang M, Wang B, Zhang L, Fang M, Zhou F. Chemoresistance and metastasis in breast cancer molecular mechanisms and novel clinical strategies. Front Oncol 2021; 11:658552.
51. Classen F, Kranz P, Riffkin H, Pompsch M, Wolf A, Göpelt K, et al. Autophagy induced by ionizing radiation promotes cell death over survival in human colorectal cancer cells. Exp Cell Res 2019; 374:29-37.
52. Sia J, Szmyd R, Hau E, Gee HE. Molecular mechanisms of radiation-induced cancer cell death: A primer. Front Cell Dev Biol 2020; 8:41-48.
53. Han MW, Lee JC, Choi JY, Kim GC, Chang HW, Nam HY, et al. Autophagy inhibition can overcome radioresistance in breast cancer cells through suppression of TAK1 activation. Anticancer Res 2014; 34:1449-1455.
54. Zhou ZR, Yang ZZ, Wang SJ, Zhang L, Luo JR, Feng Y, et al. The Chk1 inhibitor MK-8776 increases the radiosensitivity of human triple-negative breast cancer by inhibiting autophagy. Acta Pharmacol Sin 2017; 38:513-523.
55. Chaachouay H, Ohneseit P, Toulany M, Kehlbach R, Multhoff G, Rodemann HP. Autophagy contributes to resistance of tumor cells to ionizing radiation. Radiother Oncol 2011; 99:287-292.
56. Gonçalves RM, Agnes JP, Delgobo M, de Souza PO, Thomé MP, Heimfarth L, et al. Late autophagy inhibitor chloroquine improves efficacy of the histone deacetylase inhibitor SAHA and temozolomide in gliomas. Biochem Pharmacol 2019; 163:440-450.
57. Cufí S, Vazquez-Martin A, Oliveras-Ferraros C, Corominas-Faja B, Cuyàs E, López-Bonet E, et al. The anti-malarial chloroquine overcomes primary resistance and restores sensitivity to trastuzumab in HER2-positive breast cancer. Sci Rep 2013; 3:2469-2481.
58. Cocco S, Leone A, Roca MS, Lombardi R, Piezzo M, Caputo R, et al. Inhibition of autophagy by chloroquine prevents resistance to PI3K/AKT inhibitors and potentiates their antitumor effect in combination with paclitaxel in triple negative breast cancer models. J Transl Med 2022; 20:290-306.
59. Gong C, Hu C, Gu F, Xia Q, Yao C, Zhang L, et al. Co-delivery of autophagy inhibitor ATG7 siRNA and docetaxel for breast cancer treatment. J Control Release 2017; 266:272-286.
60. Das CK, Linder B, Bonn F, Rothweiler F, Dikic I, Michaelis M, et al. BAG3 overexpression and cytoprotective autophagy mediate apoptosis resistance in chemoresistant breast cancer cells. Neoplasia 2018; 20:263-279.
61. Naimo GD, Gelsomino L, Catalano S, Mauro L, Andò S. Interfering role of ERα on adiponectin action in breast cancer. Front Endocrinol (Lausanne) 2020; 11:66-75.
62. Chung SJ, Nagaraju GP, Nagalingam A, Muniraj N, Kuppusamy P, Walker A, et al. ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis. Autophagy 2017; 13:1386-1403.
63. Bajbouj K, Shafarin J, Taneera J, Hamad M. Estrogen signaling induces mitochondrial dysfunction-associated autophagy and senescence in breast cancer cells. Biology (Basel) 2020; 9:1-14.
64. Thomas S, Thurn KT, Biçaku E, Marchion DC, Münster PN. Addition of a histone deacetylase inhibitor redirects tamoxifen-treated breast cancer cells into apoptosis, which is opposed by the induction of autophagy. Breast Cancer Res Treat 2011; 130:437-447.
65. Nagelkerke A, Sieuwerts AM, Bussink J, Sweep FC, Look MP, Foekens JA, et al. LAMP3 is involved in tamoxifen resistance in breast cancer cells through the modulation of autophagy. Endocr Relat Cancer 2014; 21:101-112.
66. Li Q, Zan L. Knockdown of ATG4A inhibits breast cancer progression and promotes tamoxifen chemosensitivity by suppressing autophagy. Mol Med Rep 2022; 25:101-109.
67. Samaddar JS, Gaddy VT, Duplantier J, Thandavan SP, Shah M, Smith MJ, et al. A role for macroautophagy in protection against 4-hydroxytamoxifen-induced cell death and the development of antiestrogen resistance. Mol Cancer Ther 2008; 7:2977-2987.
68. Amaral C, Augusto TV, Tavares-da-Silva E, Roleira FMF, Correia-da-Silva G, Teixeira N. Hormone-dependent breast cancer: Targeting autophagy and PI3K overcomes exemestane-acquired resistance. J Steroid Biochem Mol Biol 2018; 183:51-61.
69. Augusto TV, Amaral C, Almeida CF, Teixeira N, Correia-da-Silva G. Differential biological effects of aromatase inhibitors: Apoptosis, autophagy, senescence and modulation of the hormonal status in breast cancer cells. Mol Cell Endocrinol 2021; 537:111426.
70. Amaral C, Borges M, Melo S, da Silva ET, Correia-da-Silva G, Teixeira N. Apoptosis and autophagy in breast cancer cells following exemestane treatment. PLoS One 2012; 7:e42398.
71. Augusto TV, Amaral C, Wang Y, Chen S, Almeida CF, Teixeira N, et al. Effects of PI3K inhibition in AI-resistant breast cancer cell lines: Autophagy, apoptosis, and cell cycle progression. Breast Cancer Res Treat 2021; 190:227-240.
72. Schlam I, Swain SM. HER2-positive breast cancer and tyrosine kinase inhibitors: the time is now. NPJ Breast Cancer 2021; 7:56-67.
73. Chen S, Zhu X, Qiao H, Ye M, Lai X, Yu S, et al. Protective autophagy promotes the resistance of HER2-positive breast cancer cells to lapatinib. Tumour Biol 2016; 37:2321-2331.
74. Mele L, la Noce M, Paino F, Regad T, Wagner S, Liccardo D, et al. Glucose-6-phosphate dehydrogenase blockade potentiates tyrosine kinase inhibitor effect on breast cancer cells through autophagy perturbation. J Exp Clin Cancer Res 2019; 38:160-172.
75. Wang J, Xu B. Targeted therapeutic options and future perspectives for HER2-positive breast cancer. Signal Transduct Target Ther 2019; 4:34-56.
76. Liu P, Fan J, Wang Z, Zai W, Song P, Li Y, et al. The role of autophagy in the cytotoxicity induced by trastuzumab emtansine (T-DM1) in HER2-positive breast cancer cells. AMB Express 2020; 10:107-116.
77. Lisiak N, Toton E, Rybczynska M. Autophagy as a potential therapeutic target in breast cancer treatment. Curr Cancer Drug Targets 2018; 18:629-639.
78. Nunes J, Zhang H, Angelopoulos N, Chhetri J, Osipo C, Grothey A, et al. ATG9A loss confers resistance to trastuzumab via c-Cbl mediated Her2 degradation. Oncotarget 2016; 7:27599-27612.
79. Qaderi MM, Martel AB, Strugnell CA. Environmental factors regulate plant secondary metabolites. Plants 2023; 12:447-473.
80. Baena Ruiz R, Salinas Hernández P. Cancer chemoprevention by dietary phytochemicals: Epidemiological evidence. Maturitas 2016; 94:13-19.
81. Sinha D, Sarkar N, Biswas J, Bishayee A. Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms. Semin Cancer Biol 2016; 40-41:209-232.
82. Rajabi S, Maresca M, Yumashev AV, Choopani R, Hajimehdipoor H. The most competent plant-derived natural products for targeting apoptosis in cancer therapy. Biomolecules 2021; 11:534-562.
83. Yang X, Zheng Y, Liu L, Huang J, Wang F, Zhang J. Progress on the study of the anticancer effects of artesunate. Oncol Lett 2021; 22:750-761.
84. Chen K, Shou LM, Lin F, Duan WM, Wu MY, Xie X, et al. Artesunate induces G2/M cell cycle arrest through autophagy induction in breast cancer cells. Anticancer Drugs 2014; 25:652-662.
85. Guan X, Guan Y. Artemisinin induces selective and potent anticancer effects in drug resistant breast cancer cells by inducing cellular apoptosis and autophagy and G2/M cell cycle arrest. J BUON 2020; 25:1330-1336.
86. Hamacher-Brady A, Stein HA, Turschner S, Toegel I, Mora R, Jennewein N, et al. Artesunate activates mitochondrial apoptosis in breast cancer cells via iron-catalyzed lysosomal reactive oxygen species production. J Biol Chem, 2011; 286:6587-6601.
87. Gu L, Zhang J, Liu D, Chen J, Liu S, Peng Q, et al. Development of artesunate intelligent prodrug liposomes based on mitochondrial targeting strategy. J Nanobiotechnology 2022; 20:376-396.
88. Wang M, Qiu S, Qin J. Baicalein induced apoptosis and autophagy of undifferentiated thyroid cancer cells by the ERK/PI3K/Akt pathway. Am J Transl Res 2019; 11:3341-3352.
89. Liu B, Ding L, Zhang L, Wang S, Wang Y, Wang B, et al. Baicalein induces autophagy and apoptosis through AMPK pathway in human glioma cells. Am J Chin Med 2019; 47:1405-1418.
90. Yan W, Ma X, Zhao X, Zhang S. Baicalein induces apoptosis and autophagy of breast cancer cells via inhibiting PI3K/AKT pathway in vivo and vitro. Drug Des Devel Ther 2018; 12:3961-3972.
91. Hua F, Xiao Y-Y, Qu X-H, Li S-S, Zhang K, Zhou C, et al. Baicalein sensitizes triple negative breast cancer MDA-MB-231 cells to doxorubicin via autophagy-mediated down-regulation of CDK1. Mol Cell Biochem 2022; 478:1519-1531.
92. Aryal P, Kim K, Park PH, Ham S, Cho J, Song K. Baicalein induces autophagic cell death through AMPK/ULK1 activation and downregulation of m TORC 1 complex components in human cancer cells. FEBS J 2014; 281:4644-4658.
93. Hsu CY, Rajabi S, Hamzeloo-Moghadam M, Kumar A, Maresca M, Ghildiyal P. Sesquiterpene lactones as emerging biomolecules to cease cancer by targeting apoptosis. Front Pharmacol 2024; 15:1371002.
94. Rajabi S, Irani M, Moeinifard M, Hamzeloo-Moghadam M. Britannin suppresses MCF-7 breast cancer cell growth by inducing apoptosis and inhibiting autophagy. Avicenna J Phytomed 2024; 14:90-99.
95. Shi J, Li J, Xu Z, Chen L, Luo R, Zhang C, et al. Celastrol: A review of useful strategies overcoming its limitation in anticancer application. Front Pharmacol 2020; 11:558741.
96. Feng Y, Zhang B, Lv J, Zhang P, Mao Q, Lin F, et al. Scaffold hopping of celastrol provides derivatives containing pepper ring, pyrazine and oxazole substructures as potent autophagy inducers against breast cancer cell line MCF-7. Eur J Med Chem 2022; 234:114254.
97. Wang L, Tang L, Yao C, Liu C, Shu Y. The synergistic effects of celastrol in combination with tamoxifen on apoptosis and autophagy in MCF-7 cells. J Immunol Res 2021; 2021:5532269.
98. Varela C, Melim C, Neves BG, Sharifi-Rad J, Calina D, Mamurova A, et al. Cucurbitacins as potential anticancer agents: new insights on molecular mechanisms. J Transl Med 2022; 20:630-645.
99. Duangmano S, Dakeng S, Jiratchariyakul W, Suksamrarn A, Smith DR, Patmasiriwat P. Antiproliferative effects of cucurbitacin B in breast cancer cells: down-regulation of the c-Myc/hTERT/telomerase pathway and obstruction of the cell cycle. Int J Mol Sci 2010; 11:5323-5338.
100. Thoennissen NH, Iwanski GB, Doan NB, Okamoto R, Lin P, Abbassi S, et al. Cucurbitacin B induces apoptosis by inhibition of the JAK/STAT pathway and potentiates antiproliferative effects of gemcitabine on pancreatic cancer cells. Cancer Res 2009; 69:5876-5884.
101. Chan KT, Meng FY, Li Q, Ho CY, Lam TS, To Y, et al. Cucurbitacin B induces apoptosis and S phase cell cycle arrest in BEL-7402 human hepatocellular carcinoma cells and is effective via oral administration. Cancer Lett 2010; 294:118-124.
102. Ren G, Sha T, Guo J, Li W, Lu J, Chen X. Cucurbitacin B induces DNA damage and autophagy mediated by reactive oxygen species (ROS) in MCF-7 breast cancer cells. J Nat Med 2015; 69:522-530.
103. Hewlings SJ, Kalman DS. Curcumin: A review of its effects on human health. Foods 2017; 6:92-102.
104. Guan F, Ding Y, Zhang Y, Zhou Y, Li M, Wang C. Curcumin suppresses proliferation and migration of MDA-MB-231 breast cancer cells through autophagy-dependent Akt degradation. PLoS One 2016; 11:e0146553.
105. Xiao-ai L, Bei W, Xiao-hong X, Lei P, Bin W, Xiao-xue D, et al. Curcumin re-sensitizes multidrug resistant (MDR) breast cancer to cisplatin through inducing autophagy by decreasing CCAT1 expression. RSC Advances 2017; 7:33572-33579.
106. Khorsandi K, Hosseinzadeh R, Shahidi FK. Photodynamic treatment with anionic nanoclays containing curcumin on human triple‐negative breast cancer cells: Cellular and biochemical studies. J Cell Biochem 2019; 120:4998-5009.
107. Wang K, Zhang C, Bao J, Jia X, Liang Y, Wang X, et al. Synergistic chemopreventive effects of curcumin and berberine on human breast cancer cells through induction of apoptosis and autophagic cell death. Sci Rep 2016; 6:1-14.
108. Rajabi S, Tahmasvand Z, Maresca M, Hamzeloo-Moghadam M. Gaillardin inhibits autophagy and induces apoptosis in MCF-7 breast cancer cells by regulating JAK/STAT pathway. Mol Biol Rep 2024; 51:158.
109. Huang S, Xie T, Liu W. Icariin inhibits the growth of human cervical cancer cells by inducing apoptosis and autophagy by targeting mTOR/PI3K/AKT signalling pathway. J BUON 2019; 24:990-996.
110. Jiang S, Chang H, Deng S, Fan D. Icariin enhances the chemosensitivity of cisplatin‑resistant ovarian cancer cells by suppressing autophagy via activation of the AKT/mTOR/ATG5 pathway. Int J Oncol 2019; 54:1933-1942.
111. Jiang S, Chang H, Deng S, Fan D. Icariin inhibits autophagy and promotes apoptosis in SKVCR cells through mTOR signal pathway. Cell Mol Biol (Noisy-le-grand) 2018; 64:4-10.
112. Cheng X, Tan S, Duan F, Yuan Q, Li Q, Deng G. Icariin induces apoptosis by suppressing autophagy in tamoxifen-resistant breast cancer cell line MCF-7/TAM. Breast Cancer 2019; 26:766-775.
113. Wang Y-X, Jin Y-Y, Wang J, Zhao Z-C, Xue K-W, Xiong H, et al. Icaritin derivative IC2 induces cytoprotective autophagy of breast cancer cells via SCD1 inhibition. Molecules 2023; 28:1109-1122.
114. Wu CL, Liu JF, Liu Y, Wang YX, Fu KF, Yu XJ, et al. Beclin1 inhibition enhances paclitaxel‑mediated cytotoxicity in breast cancer in vitro and in vivo. Int J Mol Med 2019; 43:1866-1878.
115. Zhang SF, Wang XY, Fu ZQ, Peng QH, Zhang JY, Ye F, et al. TXNDC17 promotes paclitaxel resistance via inducing autophagy in ovarian cancer. Autophagy 2015; 11:225-238.
116. Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y, et al. Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 2011; 307:141-148.
117. Song Y, Li W, Peng X, Xie J, Li H, Tan G. Inhibition of autophagy results in a reversal of taxol resistance in nasopharyngeal carcinoma by enhancing taxol-induced caspase-dependent apoptosis. Am J Transl Res 2017; 9:1934-1942.
118. Škubník J, Pavlíčková VS, Ruml T, Rimpelová S. Autophagy in cancer resistance to paclitaxel: Development of combination strategies. Biomed Pharmacothe 2023; 161:114458.
119. Wang RX, Xu XE, Huang L, Chen S, Shao ZM. eEF2 kinase mediated autophagy as a potential therapeutic target for paclitaxel-resistant triple-negative breast cancer. Ann Transl Med 2019; 7:783-795.
120. Wen J, Yeo S, Wang C, Chen S, Sun S, Haas MA, et al. Autophagy inhibition re-sensitizes pulse stimulation-selected paclitaxel-resistant triple negative breast cancer cells to chemotherapy-induced apoptosis. Breast Cancer Res Treat 2015; 149:619-629.
121. Hu W, Zheng W, Du J, Tian Z, Zhao Y, Zhao P, et al. TIPE2 sensitizes breast cancer cells to paclitaxel by suppressing drug-induced autophagy and cancer stem cell properties. Hum Cell 2023; 36:1485-1500.
122. Pai Bellare G, Sankar Patro B. Resveratrol sensitizes breast cancer to PARP inhibitor, talazoparib through dual inhibition of AKT and autophagy flux. Biochem Pharmacol 2022; 199:115024.
123. Alayev A, Berger SM, Kramer MY, Schwartz NS, Holz MK. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells. J Cell Biochem 2015; 116:450-457.
124. Siddiqui A, Dandawate P, Rub R, Padhye S, Aphale S, Moghe A, et al. Novel aza-resveratrol analogs: Synthesis, characterization and anticancer activity against breast cancer cell lines. Bioorg Med Chem Lett 2013; 23:635-640.
125. Fu Y, Chang H, Peng X, Bai Q, Yi L, Zhou Y, et al. Resveratrol inhibits breast cancer stem-like cells and induces autophagy via suppressing Wnt/β-catenin signaling pathway. PLoS One, 2014; 9:e102535.
126.Wang J, Huang P, Pan X, Xia C, Zhang H, Zhao H, et al. Resveratrol reverses TGF‐β1‐mediated invasion and metastasis of breast cancer cells via the SIRT3/AMPK/autophagy signal axis. Phytother Res 2023; 37:211-230.
127. Rai G, Suman S, Mishra S, Shukla Y. Evaluation of growth inhibitory response of resveratrol and salinomycin combinations against triple negative breast cancer cells. Biomed Pharmacother, 2017; 89:1142-1151.
128. Scarlatti F, Maffei R, Beau I, Codogno P, Ghidoni R. Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells. Cell Death Differ 2008; 15:1318-1329.
129. Luan F, He X, Zeng N. Tetrandrine: A review of its anticancer potentials, clinical settings, pharmacokinetics and drug delivery systems. J Pharm Pharmacol 2020; 72:1491-1512.
130. Guo Y, Pei X. Tetrandrine-induced autophagy in MDA-MB-231 triple-negative breast cancer cell through the inhibition of PI3K/AKT/mTOR signaling. Evid Based Complement Alternat Med 2019; 2019:7517431.
131. Wong VKW, Zeng W, Chen J, Yao XJ, Leung ELH, Wang QQ, et al. Tetrandrine, an activator of autophagy, induces autophagic cell death via PKC-α Inhibition and mTOR-Dependent Mechanisms. Front Pharmacol 2017; 8:351-363.
132. Wang Y, Yue W, Lang H, Ding X, Chen X, Chen H. Resuming sensitivity of tamoxifen-resistant breast cancer cells to tamoxifen by tetrandrine. Integr Cancer Ther 2021; 20:1534735421996822.
133. Yao M, Yuan B, Wang X, Sato A, Sakuma K, Kaneko K, et al. Synergistic cytotoxic effects of arsenite and tetrandrine in human breast cancer cell line MCF-7. Int J Oncol 2017; 51:587-598.
134. Xu H, Liu B, Xiao Z, Zhou M, Ge L, Jia F, et al. Computational and experimental studies reveal that thymoquinone blocks the entry of coronaviruses into in vitro cells. Infect Dis Ther 2021; 10:483-494.
135. Ünal TD, Hamurcu Z, Delibaşı N, Çınar V, Güler A, Gökçe S, et al. Thymoquinone inhibits proliferation and migration of MDA-MB-231 triple negative breast cancer cells by suppressing autophagy, Beclin-1 and LC3. Anticancer Agents Med Chem 2021; 21:355-364.
136. Bashmail HA, Alamoudi AA, Noorwali A, Hegazy GA, G AJ, Choudhry H, et al. Thymoquinone synergizes gemcitabine anti-breast cancer activity via modulating its apoptotic and autophagic activities. Sci Rep 2018; 8:11674-11684.
137. Bashmail HA, Alamoudi AA, Noorwali A, Hegazy GA, Ajabnoor GM, Al-Abd AM. Thymoquinone enhances paclitaxel anti-breast cancer activity via inhibiting tumor-associated stem cells despite apparent mathematical antagonism. Molecules 2020; 25:426-440.
138. Alkhatib MH, Bawadud RS, Gashlan HM. Incorporation of docetaxel and thymoquinone in borage nanoemulsion potentiates their antineoplastic activity in breast cancer cells. Sci Rep 2020; 10:18124-18135.
139. Ahsan H, Ahad A, Iqbal J, Siddiqui WA. Pharmacological potential of tocotrienols: a review. Nutr Metab (Lond) 2014; 11:52.
140. McIntyre BS, Briski KP, Tirmenstein MA, Fariss MW, Gapor A, Sylvester PW. Antiproliferative and apoptotic effects of tocopherols and tocotrienols on normal mouse mammary epithelial cells. Lipids 2000; 35:171-180.
141. Tiwari RV, Parajuli P, Sylvester PW. γ-Tocotrienol-induced autophagy in malignant mammary cancer cells. Exp Biol Med (Maywood) 2014; 239:33-44.
142. Tiwari RV, Parajuli P, Sylvester PW. γ-Tocotrienol-induced endoplasmic reticulum stress and autophagy act concurrently to promote breast cancer cell death. Biochem Cell Biol 2015; 93:306-320.
143. Tiwari RV, Parajuli P, Sylvester PW. Synergistic anticancer effects of combined γ-tocotrienol and oridonin treatment is associated with the induction of autophagy. Mol Cell Biochem 2015; 408:123-137.
144. Lewinska A, Adamczyk-Grochala J, Kwasniewicz E, Deregowska A, Wnuk M. Ursolic acid-mediated changes in glycolytic pathway promote cytotoxic autophagy and apoptosis in phenotypically different breast cancer cells. Apoptosis 2017; 22:800-815.
145. Wang Z, Zhang P, Jiang H, Sun B, Luo H, Jia A. Ursolic acid enhances the sensitivity of MCF-7 and MDA-MB-231 cells to epirubicin by modulating the autophagy pathway. Molecules 2022; 27:3399-3416.
146. Luo J, Hu YL, Wang H. Ursolic acid inhibits breast cancer growth by inhibiting proliferation, inducing autophagy and apoptosis, and suppressing inflammatory responses via the PI3K/AKT and NF‑κB signaling pathways in vitro. Exp Ther Med 2017; 14:3623-3631.
147. Zhao C, Yin S, Dong Y, Guo X, Fan L, Ye M, et al. Autophagy-dependent EIF2AK3 activation compromises ursolic acid-induced apoptosis through upregulation of MCL1 in MCF-7 human breast cancer cells. Autophagy 2013; 9:196-207.
148. Lin PW, Chu ML, Liu HS. Autophagy and metabolism. Kaohsiung J Med Sci 2021; 37:12-19.
149. Kroemer G, Mariño G, Levine B. Autophagy and the integrated stress response. Mol Cell 2010; 40:280-293.
150. Ouyang L, Shi Z, Zhao S, Wang FT, Zhou TT, Liu B, et al. Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif 2012; 45:487-498.
151. Carew JS, Kelly KR, Nawrocki ST. Autophagy as a target for cancer therapy: new developments. Cancer Manag Res, 2012; 4:357.
152. Arnaout A, Robertson SJ, Pond GR, Lee H, Jeong A, Ianni L, et al. A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients. Breast Cancer Res Trea 2019; 178:327-335.
153. von Hagens C, Walter-Sack I, Goeckenjan M, Storch-Hagenlocher B, Sertel S, Elsässer M, et al. Long-term add-on therapy (compassionate use) with oral artesunate in patients with metastatic breast cancer after participating in a phase I study (ARTIC M33/2). Phytomedicine 2019; 54:140-148.
154. Chang H, Zou Z. Targeting autophagy to overcome drug resistance: further developments. J Hematol Oncol 2020; 13:159.
155. Ahn JS, Ann EJ, Kim MY, Yoon JH, Lee HJ, Jo EH, et al. Autophagy negatively regulates tumor cell proliferation through phosphorylation dependent degradation of the Notch1 intracellular domain. Oncotarget 2016; 7:79047-79063.
)